Skip to main content

Table 1 Demographic data of all 168 patients included in the study

From: Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery

 

THR

TKR

Total

Treated, n (%)

81 (100.0)

87 (100.0)

168 (100.0)

Gender, n (%)

   

Male

40 (49.4)

32 (36.8)

72 (42.9)

Female

41 (50.6)

55 (63.2)

96 (57.1)

Age (years), median (Q1, Q3)

60.0 (52.0, 66.0)

64.0 (57.0, 69.0)

62.0 (55.0, 68.0)

Age class, n (%)

   

<65 years

55 (67.9)

47 (54.0)

102 (60.7)

65-75 years

26 (32.1)

39 (44.8)

65 (38.7)

>75 years

0

1 (1.1)

1 (0.6)

Body mass index (kg/m2), median (Q1, Q3)

27.2 (24.3, 29.8)

29.8 (26.8, 34.3)

28.4 (25.7, 32.5)

Body mass index class, n (%)

   

<25 kg/m2

25 (30.9)

11 (12.6)

36 (21.4)

25 – <30 kg/m2

37 (45.7)

33 (37.9)

70 (41.7)

30–35 kg/m2

11 (13.6)

26 (29.9)

37 (22.0)

>35 kg/m2

8 (9.9)

17 (19.5)

25 (14.9)

  1. Q Quartile, THR Total hip replacement, TKR Total knee replacement